Background: Little up-to-date information is available about the costs of providing drug-susceptible tuberculosis (DS-TB) treatment to paediatric patients in South Africa (SA), nor have actual costs incurred at clinics been compared with costs expected from guidelines.
Governance
Resource
February 27, 2019
Event
February 27, 2019
This webinar, on addressing the SRH needs of adolescents and young people living with HIV , which is part of the 2019 SRHR and HIV Linkages webinar series
Resource
February 27, 2019
One policy reform aimed at maintaining the critical role of civil society in the HIV response in concert with domestic resource mobilization efforts is the development of government-led mechanisms to finance civil society through formalized contractual channels.
News
February 26, 2019
Preventing maternal and child deaths, creating an AIDS-free generation, and protecting communities from infectious disease threats needs efficient pharmaceutical services and treatment with quality medicines.
Opportunity
February 25, 2019
Panagora Group's Monitoring, Evaluation, Research, and Learning (MERL) Activity supports USAID/South Africa’s bilateral Health Office by working collaboratively with health office staff to achieve their overall goals by creatively finding innovative solutions, supplementing and complementing their existing staff capacity, and as appropriate enhancing capacity in performance management; evaluation and research; and systematic collaboration, continuous learning, and adaptive management. We are looking for creative, dynamic, results focused and experienced professionals to be part of a pool of consultants that we can call on to support USAID/South Africa’s bilateral Health Office with a variety of needs in the area of HIV and AIDS.
Resource
February 5, 2019
The PrEP Costing Guidelines provide a framework for estimating the cost of providing pre-exposure prophylaxis (PrEP), which is the use of antiretroviral (ARV) drugs for preventing the acquisition of HIV infection.
Resource
February 5, 2019
Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and recommended tenofovir disoproxil fumarate (TDF
Resource
January 30, 2019
As part of its Monitoring, Evaluation, and Reporting (MER) guidance, the United States President’s Emergency Plan for AIDS Relief (PEPFAR) released Version 2.3 in September 2018, which includes revised indicators for orphans and vulnerable children (OVC) programs.
Resource
January 29, 2019
BACKGROUND: South Africa's prevention of mother-to-child transmission (PMTCT) of the human immunodeficiency virus (HIV) prog
Resource
January 28, 2019
In our sixth issue, we have assembled 105 abstracts published from October through December 2018 that feature evidence from Botswana (4), Eswatini (5), Lesotho (2), Malawi (8), Mozambique (6), Namibia (2), South Africa (62), Tanzania (1), Zambia (12) and Zimbabwe (10).
